Skip to content

What is relief from tinnitus worth?

A good night’s sleep, quiet conversations with friends, peace of mind. If you have tinnitus, it’s the simple things you can’t put a price on that can feel just out of reach. Lenire could be able to help.

The Tinnitus Challenge

If you have tinnitus, you’re not alone. It’s a common medical condition estimated to affect 10-15% of the global population. The British Tinnitus Association estimate that 1 in 8 people in the UK have tinnitus. It’s a neurological issue which people experience as a sound that does not have an external source.

Due to the nature of tinnitus, finding a clinically effective treatment for the majority of patients remains a significant challenge for the healthcare ecosystem.

Did you know that:

  • Patients with tinnitus had more primary health care visits compared to people without tinnitus, with an average of four more primary care consultations in one year. They were also more frequently referred to medical specialists.1
  • In the UK, a Neuromod poll found that 76% of tinnitus patients have never used any form of tinnitus treatment with almost 60% of patients not feeling informed about their tinnitus treatment options.2
  • The cost to the UK healthcare system for one quality adjusted life year (QALY) gained for tinnitus patients is £10,600.3 A QALY is a healthcare measure for a year of good health.
  • As of July 2021, 58.8% of people on NHS England waiting lists for ENTs were waiting up to 18 weeks for referral to treatment.4

What if you could overcome these healthcare challenges and enjoy the simple things again by investing in your own tinnitus treatment and starting it in days?

Lenire Can Help

Lenire is a tinnitus treatment device which has shown to be effective in reducing the symptoms of tinnitus.

In a recent large scale clinical trial5:

  • 86.2% of treatment compliant participants reported improvement in tinnitus symptoms after 12 weeks of treatment.6
  • Encouragingly 80.1% of compliant participants reported a reduction that was sustained for 12 months after treatment ended.

Lenire is now available in the UK for people with tinnitus through private practice from £2,300. Book your free introductory call with our team to discuss how you can get started in days.

Need more information?

Book a free introductory call to learn more

How Lenire Works

Lenire applies bimodal neuromodulation, the pairing of mild electrical stimulation to the tongue with sound stimulation. This pairing works to retrain neurons in the brain to reduce its attention and sensitivity to the tinnitus sound.


The Lenire Device

headphones
Headphones

Customised sounds are played through Bluetooth® headphones to activate the auditory nerve.

Tonguetip
Tonguetip

Mild and safe energy pulses are delivered to the surface of the tip of the tongue to activate nerves to the brain.

Lenire controller
The Lenire Controller

A lightweight, handheld device that controls the time and intensity of the treatment.

The Treatment

Lenire is prescribed for you by our qualified healthcare professionals after an assessment of your tinnitus. The device’s sound and tongue stimulation are configured specifically for your tinnitus which enables you to self-administer your personalised treatment plan from the comfort of your own home.

  1. Intro call

    Free
    HideShow

    Your intro call with our team is free. Discuss your experience with tinnitus and get information about Lenire. Then you can decide if you wish to proceed with an audiological assessment for your tinnitus.

    We’ll confirm some details and get a better understanding about how your tinnitus impacts your daily life.

  2. Tinnitus Assessment

    £85
    HideShow

    Your tinnitus assessment will determine if Lenire is a suitable treatment option for you or if another treatment is recommended.

    The assessment is carried out online by our audiologists who specialise in tinnitus. You’ll receive a clinical evaluation including a review of your medical, audiological, and tinnitus history.

     

  3. Getting Your Lenire Device

    From £2,300
    HideShow

    If Lenire is deemed suitable for you and prescribed by our healthcare professionals, the device’s audio and tongue stimulation parameters are configured based on your tinnitus and audiological profile. This allows the healthcare professional to tailor the treatment to you. You’ll have a fitting session with our team, to make sure you are happy and comfortable using the device.

    You can purchase Lenire up front for £2,300.

    Payment plans are available allowing you to pay for the Lenire device in three separate installments of £800 up front, £800 at your first follow up assessment, and £900 at your second follow up assessment.

    Book an intro call with our team today to discuss your payment plan options in detail.

     

  4. Home Use

    Daily use of Lenire as per your treatment plan
    HideShow

    After being shown how to use Lenire during your fitting, you’ll use Lenire from the comfort of home for 30 to 60 minutes per day or as per your treatment plan.

  5. Follow-Up Appointments

    £0 (included when you purchase Lenire)
    HideShow

    We recommend a follow-up appointment with our healthcare professionals approximately six to 12 weeks after your device fitting. Another follow-up appointment should take place a further six to 12 weeks after the first.

    This allows us to assess your progress and answer your questions. Our healthcare professionals may decide to reconfigure your Lenire device during these appointments to get the best outcome for you.

    There’s no charge for these appointments, they’re included in your purchase of Lenire.

  6. Continued Use

    After the treatment plan
    HideShow

    At the end of the prescribed treatment plan, our healthcare professionals will advise you on your continued use of the Lenire device.

    You own your Lenire device and it’s yours to keep.

1Rademaker et al, 2021
2Neuromod research, 2021
3Stockdale et al, 2017
4NHS England Statistics, July 2021
5Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)
6As measured by Tinnitus Handicap Inventory